LBG Biopharma

Latham BioPharm Group (LBG) is a leading life sciences advisory firm that provides strategic, technical, and operational support to biotechnology and pharmaceutical companies, as well as government agencies. The company specializes in non-dilutive funding, product development, and CMC (Chemistry, Manufacturing, and Controls) services to help clients navigate the complexities of the drug development lifecycle. LBG is particularly well-regarded for its expertise in securing and managing government contracts and grants from agencies such as BARDA, NIH, and DoD. In 2022, the firm was acquired by Sia Partners, expanding its global reach and integrating its specialized life science capabilities into a broader management consulting framework.